You-tACS
ACTRN12618001705279
Treatment
Not Applicable
Charities/Societies/Foundations,Perpetual Foundation IMPACT Philanthropy Program
Dr Manreena Kaur
This study aims to test the effectiveness of Transcranial Alternating Current Stimulation (tACS), a gentle non-invasive brain stimulation technique, in treating young people (16-30 years old) with depression. Participants will be randomised into three groups; theta tACS, alpha tACS or sham stimulation and will receive 30 treatment sessions over four-weeks. Depressive symptoms and cognition will be assessed pre-treatment, mid-treatment phase, post-treatment and at 3 month follow-up. It is anticip .... Read more
-Diagnosis of major depressive episode (MDE), in accordance with the Mini International Neuropsychiatric Interview - Individuals between 16 to 30 years of age - Depression severity quantified using the Montgomery-Asberg Depression Rating Scale (MADRS) cut-off scores (mild: 7-19; moderate: 20-34; severe: >34) - No more than 2 previously received adequate trials of antidepressant treatment - Demonstrated capacity to give informed consent
-Inability to give informed consent -DSM V diagnoses of a psychotic disorder or current substance-use disorders; -Developmental disorders (including autism); -History of sustained head injury; -Other neurological illness; -Intellectual disability; -Major medical illness impacting brain function -Pregnancy
No
Sample Size 55
Min. age 16 Years
Max. age 30 Years
Sex Both males and females
Condition category Early stage Depression
Condition code Mental Health
Intervention code Treatment: Devices
tACS treatment frequency will be determined during an EEG recording (see EEG assessment section below for details on EEG recording equipment). During the EEG recording, the N-back working memory task will be administered to participants to elicit theta oscillations, and the Sternberg working memory task will be administered to elicit alpha oscillations. Stimulation frequency will then be set to each individual’s theta and alpha frequency measurements, depending on the treatment allocated. The cu .... Read more
Control group Placebo
Sham protocol: Sham stimulation is achieved by applying a period of 2 minutes of tACS at 13 Hz (i.e. a low beta frequency) with a 10 second ramp on and 10 second ramp off to provide the participant an experience of stimulation. The switching off of the stimulation pre-programmed within the software of the device. The participant will just turn the device on for 20 minutes without any indication of the type of stimulation. There is no evidence that the brief 120 second period of stimulation produ .... Read more
Outcome: Changes in severity of depressive symptoms as measured by change in Montgomery-Asberg Depression Rating Scale (MADRS) scores.Timepoint: Baseline, 4 weeks (end-point)
Outcome: Changes in severity of depressive symptoms as measured by change in Beck Depression Inventory (BDI) scores.Timepoint: Baseline, 4 weeks (end-point)
Outcome: Changes in severity of depressive symptoms as measured by change in Five Facet Mindfulness Questionnaire (FFMQ) scores.Timepoint: Baseline, 4 weeks (end-point)
yes
The data set will be shared, in de-identified form only.
Available following publication, and no end date determined.
Available on a case-by-case basis at the discretion of the Principal Investigator, dependent on the proposal and methods of those wishing to access.
Dependent on the proposal and methods of those wishing to access.